Poison Pills

Drawing on internal documents, video footage, court testimony, and exclusive interviews, as well as three decades of experience inside the medical industry, Tom Nesi tells the dramatic story of what the drug's manufacturer, Merck, knew and ...

Poison Pills

Poison Pills

To the millions of Americans who suffer from chronic pain and arthritis, Vioxx seemed like a miracle. One of the most widely promoted and prescribed pain medications in the world -- used by more than twenty million people -- it was endorsed by the medical establishment and celebrities such as Olympic champion figure skater Dorothy Hamill. With annual sales of $2.5 billion, Vioxx became a pharmaceutical bonanza before being abruptly taken off the market in September 2004, after it was revealed that it led to an increased risk of heart-related disease and death. Drawing on internal documents, video footage, court testimony, and exclusive interviews, as well as three decades of experience inside the medical industry, Tom Nesi tells the dramatic story of what the drug's manufacturer, Merck, knew and when. It is a compelling narrative of business and medical science run amok, with a cast of characters ranging from those at the highest levels of the multibillion-dollar pharmaceutical industry to research scientists, marketers, and drug company sales reps. Here also are accounts from physicians, lawyers, financial analysts, and patients and their families whose lives have been forever altered by Vioxx. Set against a fascinating history of the origins of the modern pharmaceutical industry, POISON PILLS is a shocking tale that involves the breakdown of the United States medical system, the failures of the Food and Drug Administration, and enormous profits made by a large pharmaceutical corporation at the potential cost of thousands of lives.

More Books:

Poison Pills
Language: en
Pages: 320
Authors: Tom Nesi
Categories: Business & Economics
Type: BOOK - Published: 2008-09-16 - Publisher: Macmillan

To the millions of Americans who suffer from chronic pain and arthritis, Vioxx seemed like a miracle. One of the most widely promoted and prescribed pain medications in the world -- used by more than twenty million people -- it was endorsed by the medical establishment and celebrities such as
Diversity in Multinational Corporations
Language: en
Pages: 182
Authors: Roxana Maiorescu, Brenda Wrigley
Categories: Business & Economics
Type: BOOK - Published: 2016-10-26 - Publisher: Taylor & Francis

Globalization, information and communication technologies, and the millennials who have entered the workforce, compelled corporations to change their resistant and defensive approaches to diversity and to proactively address differences. Companies determined that embracing diversity positively impacts their bottom line, as a result of the variety of perspectives and skills that
The Cambridge Companion to Business and Human Rights Law
Language: en
Pages:
Authors: Ilias Bantekas, Michael Ashley Stein
Categories: Political Science
Type: BOOK - Published: 2021-09-09 - Publisher: Cambridge University Press

How can businesses operate profitably and sustainably while ensuring that they are applying human rights? It is possible to apply human rights while at the same time decreasing cost and making human rights contribute to profits. Yet business efforts alone are insufficient, and states must possess sufficient regulatory power to
The Ethics of Animal Research
Language: en
Pages: 356
Authors: Jeremy R. Garrett
Categories: Medical
Type: BOOK - Published: 2012-03-30 - Publisher: MIT Press

A balanced, accessible discussion of whether and on what grounds animal research can be ethically justified. An estimated 100 million nonhuman vertebrates worldwide—including primates, dogs, cats, rabbits, hamsters, birds, rats, and mice—are bred, captured, or otherwise acquired every year for research purposes. Much of this research is seriously detrimental to
Pharma
Language: en
Pages: 816
Authors: Gerald Posner
Categories: Business & Economics
Type: BOOK - Published: 2021-04-13 - Publisher: Simon and Schuster

Award-winning journalist and New York Times bestselling author Gerald Posner reveals the heroes and villains of the trillion-dollar-a-year pharmaceutical industry and delivers “a withering and encyclopedic indictment of a drug industry that often seems to prioritize profits over patients (The New York Times Book Review). Pharmaceutical breakthroughs such as anti­biotics